Sign inJoin waitlistJoin the waitlist

David Akhavan

Associate Professor, Radiation Oncology · University of Kansas School of Medicine

Credentials: · · · · · ·

History

University of Kansas School of Medicine
Present

Radiation Oncology
City of Hope National Medical Center
2016–2020
Preliminary or Transitional Year
2015–2016
Molecular and Medical Pharmacology, University of California Los Angeles, Medical Scientist Training Program, Los Angeles, CA
David Geffen Sch of Med at UCLA
2010–2014

Research

An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway
Cancer Discovery · 2011 · 382 citations
mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc
Cell Metabolism · 2013 · 370 citations
EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy
Science Signaling · 2009 · 297 citations

Paul Mischel
11 papers
Timothy Cloughesy
8 papers
William Yong
5 papers
GV
Genaro Villa
4 papers
Arya Amini
3 papers
Harry Vinters
3 papers
IM
Ingo Mellinghoff
3 papers
Adip Bhargav
2 papers · 2 as a resident
Alexandra Pourzia
2 papers
Amit Noheria
2 papers
CR
Chad Rusthoven
2 papers
Fen Wang
2 papers

Grants

Design of a Novel Nanocarrier Technology to Drug-Load CAR T Cells
National Cancer Institute · R01
Contact PI · $2.3M · University of Kansas Medical Center
2023–2028

Clinical trials

vGRID SBRT: A Phase I Clinical Trial in Unresectable or Metastatic HCC
Principal investigator · Recruiting
University of Kansas Medical Center
2023–2028
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Site PI · Recruiting · Phase 3
NRG Oncology
2025–2030